Indefinite Delivery Contract SPE2DR25D1902

Award Date 4/2/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency (DLA) Troop Support awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract, which runs through December 2036, encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This single-award IDC has a base period through December 2026, with the option to extend for an additional 10 years. The contract covers critical medical commodities including specialty medications,...
The Department of Defense awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This single-award IDC, issued by the Defense Logistics Agency (DLA) Troop Support Medical, has a period of performance through December 2036. The contract encompasses critical medical commodities including specialty medications, brand-name and...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp valued at $999,999,999 through November 2036. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs,...
This Indefinite Delivery Contract (IDC) award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is valued at $999,999,999 and runs through December 2036. It serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs,...
The Defense Logistics Agency (DLA) has awarded an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 to Amerisourcebergen Drug Corp for the delivery of a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of November 30, 2026. As a major pharmaceutical distributor, Amerisourcebergen will leverage its extensive supply chain network to provide a wide array of...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies. This IDC serves as the primary vehicle for delivering brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and other critical medical commodities to support military...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This single-award IDC has a period of performance from September 2025 to December 2036 and serves as a primary vehicle for the DLA to procure critical medical commodities, including...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, valued at $999,999,999 through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military...

The contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is an Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through December 2036. The contract provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract was competitively awarded as a single-award IDC with no set-aside requirements. It serves as a primary vehicle for DLA to efficiently procure critical medical commodities needed to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. In addition to this DLA contract, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024, which covers similar pharmaceutical and medical products.

Generated 7/2/25, 10:28 PM